Azithromycin for injection

The second generation of macrolide antibiotic, total impurity less than 1%, safe reliable, less adverse effect, better curative effect; a first-line treatment for respiratory infection in children and adults, chlamydia trachomatis.

Active ingredient: Azithromycin
Description: White or off-white porous mass or powder.

Dosage Form: lyophilized powder for injection

Strength: 0.25g (250,000 units); 0.5g (500,000 units)
Storage: Sealed, kept in a cool and dry place.
Packaging: Unopened glass vials, 1 vial/box, 400 boxes/carton (Can be customized)
Shelf life: 24months
Indication: This product is suitable for the following infections caused by sensitive pathogenic strains:
1. Community-acquired pneumonia (CAP)caused by Chlamydia pneumoniae, Haemophilus influenzae, Legionella pneumophila, Moraxella catarrhalis, Mycoplasma pneumoniae, Staphylococcus aureus, or Streptococcus pneumoniae and requiresa first intravenous infusion treatment.
2. Pelvic inflammatory disease caused by chlamydia trachomatis, Neisseria gonorrhoeaeand Mycoplasma hominis and requiresa first intravenous infusion treatment.
Dosage and administration
Administration:
Prior to use, add some water for injection into the vial to dissolve the content completely to obtain a solution having a concentration of 0.1 g/ml, and transfer the dissolved solution intoa 250 ml or 500 ml of 0.9% sodium chloride injection or 5% glucose injection to obtain a solution with a final azithromycin concentration of 1.0 to 2.0 mg/ml, then followed by the intravenous infusion. The whole infusion period should be controlled at 3 hours for 1.0 mg/ml and 1 hour for 2.0 mg/ml. Intravenous infusion period should be controlled not less than 60 minutes, and the concentration of not exceed 2.0mg/ml.
Dosage:
1.CAP: 0.5g per time for adults, once a day, at least 2 consecutive days, then followed by changing to oral preparations of azithromycin of 0.5g per day, the course of treatment is 7-10 days. Changing time for oral treatment should be determined by the physician based on the clinical response.
2.Pelvic inflammatory disease: 0.5g per time for adults, once a day, after one or two days of medication, followed by changing to oral preparations of azithromycin of 0.25g per day, the course of treatment is 7 days. Changing time for oral treatment should be determined by the physician based on the clinical response.